Intrinsic Value
Relmada Therapeutics, Inc. (RLMD)
$4.65
+0.06 (+1.31%)
Enterprise Value | - |
---|---|
Net Debt | -5.40 |
Equity Value | - |
Shares Outstanding | 29.63 |
Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt